Crossmark

High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review

Crossref DOI link: https://doi.org/10.1038/s41409-018-0284-4

Published Online: 2018-08-08

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Varga, Cindy

Comenzo, Raymond L.
License Information

Text and Data Mining valid from 2018-08-08
More Information

Article History

Received: 30 March 2018

Revised: 25 May 2018

Accepted: 8 June 2018

First Online: 8 August 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.